These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18048114)

  • 21. Management of midgut carcinoids.
    Akerström G; Hellman P; Hessman O; Osmak L
    J Surg Oncol; 2005 Mar; 89(3):161-9. PubMed ID: 15719373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
    Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
    In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinoid tumors--somatostatine in the diagnosis and therapy.
    Kinova S; Duris I; Kratochvilova E; Ondrejka P; Payer J
    Bratisl Lek Listy; 2002; 103(3):108-12. PubMed ID: 12190042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids.
    Sullivan I; Le Teuff G; Guigay J; Caramella C; Berdelou A; Leboulleux S; Déandréis D; Hadoux J; Ducreux M; Duvillard P; Adam J; Scoazec JY; Baudin E; Planchard D
    Eur J Cancer; 2017 Apr; 75():259-267. PubMed ID: 28242503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical management and palliative treatment in bronchial neuroendocrine tumours: a clinical study of 45 patients.
    Srirajaskanthan R; Toumpanakis C; Karpathakis A; Marelli L; Quigley AM; Dusmet M; Meyer T; Caplin ME
    Lung Cancer; 2009 Jul; 65(1):68-73. PubMed ID: 19070398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing, treating and managing carcinoid tumours.
    Burgess A
    Nurs Times; 2005 Jul 19-25; 101(29):32-4. PubMed ID: 16052941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Orthotopic liver transplantation for metastases of bronchial carcinoid tumor].
    Le Hello C; Auvray S; Letellier P; Segol P
    Gastroenterol Clin Biol; 1992; 16(3):281-3. PubMed ID: 1349869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.
    Fossmark R; Sørdal Ø; Jianu CS; Qvigstad G; Nordrum IS; Boyce M; Waldum HL
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1067-75. PubMed ID: 23072686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurokinin A monitoring of response to interferon alpha in a patient with an advanced small bowel neuroendocrine tumour uncontrolled by somatostatin analogue therapy.
    Ardill JE; Johnston BT; McCance DR; Eatock M
    Ann Clin Biochem; 2017 Mar; 54(2):297-301. PubMed ID: 27638929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A as a determinant of midgut carcinoid tumour volume.
    Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O
    Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastroenteropancreatic neuroendocrine tumours (carcinoid tumours): definition, clinical aspects, diagnosis and therapy].
    Bodelier AG; Haak HR
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1868-72. PubMed ID: 16970007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids.
    Jianu CS; Fossmark R; Syversen U; Hauso Ø; Fykse V; Waldum HL
    Scand J Gastroenterol; 2011 Apr; 46(4):456-63. PubMed ID: 21133821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
    Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical use of somatostatin analogues in the treatment of cancer.
    Lamberts SW; Krenning EP; Klijn JG; Reubi JC
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):29-49. PubMed ID: 1975166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal carcinoid tumours. Histogenetic, histochemical, immunohistochemical, clinical and therapeutic aspects.
    Wilander E; Lundqvist M; Oberg K
    Prog Histochem Cytochem; 1989; 19(2):1-88. PubMed ID: 2662260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal neuroendocrine (carcinoid) tumours: current diagnosis and management.
    Modlin IM; Moss SF; Oberg K; Padbury R; Hicks RJ; Gustafsson BI; Wright NA; Kidd M
    Med J Aust; 2010 Jul; 193(1):46-52. PubMed ID: 20618115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurements of chromogranin B can serve as a complement to chromogranin A.
    Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
    Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacologic therapy for neuroendocrine tumours].
    Petrányi A; Bodoky G
    Orv Hetil; 2011 Mar; 152(10):379-91. PubMed ID: 21354954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumour vanishes.
    Todd JF; Meeran K
    Clin Endocrinol (Oxf); 2000 Dec; 53(6):663-4. PubMed ID: 11155085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.